Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|January 1, 1991
Comparative intraperitoneal pharmacokinetics of three platinum analoguesM J Lind, D J Murphy, H Sharma, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinomaD Murphy, M J Lind, J Prendiville, et al.Cancer|January 1, 1988
Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour GroupN Thatcher, D B Smith, M J Lind, et al.Journal of American College Health : J of ACH|December 1, 2020
Trauma exposure, alcohol consumption, and sleep quality: a latent growth curve modelS E Cusack, K E Bountress, M J Lind, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosisA G Kamthan, M J Lind, N Thatcher, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|April 8, 2000
Simultaneous determination of the peptide-mitomycin KW-2149 and its metabolites in plasma by high-performance liquid chromatographyZ D Zhang, G Guetens, G De Boeck, et al.Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients: a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT)G Freyer, B Ligneau, B Tranchand, et al.British Journal of Cancer|January 1, 1997
A clinical and pharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancerN Siddiqui, A V Boddy, H D Thomas, et al.European Journal of Cancer & Clinical Oncology|September 1, 1988
Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancerH Anderson, J Wagstaff, D Crowther, et al.British Journal of Cancer|April 1, 1992
A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancerM J Lind, B M Cantwell, M J Millward, et al.Pageof 7